Search Results - "Kelley, E. Lynne"

Advances in subcutaneous injections: PRECISE II: a study of safety and subject preference for an innovative needle-free injection system by Kelley, E. Lynne, Smith, Richard H., Corcoran, Gillian, Nygren, Sandra, Jacoski, Mary V., Fernandes, Andrea

“…Needle-free injection is a desirable goal for many reasons, including reducing pain, anxiety, and eliminating safety risks associated with needle-stick…”
Get full text

Renal artery stenting with noninvasive duplex ultrasound follow-up: 3-year results from the RENAISSANCE renal stent trial by Rocha-Singh, Krishna, Jaff, Michael R., Lynne Kelley, E.

“…Objective The multicenter, single‐arm RENAISSANCE trial evaluated outcomes in patients with progressive atherosclerotic renal artery stenosis (ARAS) treated…”
Get full text

A Randomized Trial of a Skin Sealant to Reduce the Risk of Incision Contamination in Cardiac Surgery by von Eckardstein, Abelardo Silva, MD, Lim, Chong H., MBBS, Dohmen, Pascal M., MD, PhD, Pêgo-Fernandes, Paulo M., MD, PhD, Cooper, William A., MD, Oslund, Susan G., BSN, BSChE, Kelley, E. Lynne, MD

“…Background Immobilizing skin microbes is a rational approach to reducing contamination of surgical sites by endogenous microorganisms. Methods This randomized,…”
Get full text

Advances in Large Volume Subcutaneous Injections: A Pilot Tolerability Study of an Innovative Needle-Free Injection Platform by Kelley, E Lynne, Fernandes, Andrea, Pelletier, Marc, Takami, Eri A, Emery, Christine, Dyer, Bobby, Jacoski, Mary V, Lozko, Valery, Burgess, Bart, Smith, Richard H

“…Many medical conditions require chronic treatment with subcutaneous injectable biologics often exceeding 1.0 mL. However, subcutaneous administration of…”
Get more information

Abstract C004: The CXCR4 inhibitor X4-136 enhances the in vivo efficacy of established drugs against preclinical models of aggressive pediatric acute lymphoblastic leukemia by Lock, Richard B, Evans, Kathryn, Jones, Connor D, El-Zein, Narimanne, Erickson, Stephen W, Beaussant-Cohen, Sarah, Kelley, E. Lynne, Teicher, Beverly A, Smith, Malcolm A

“…Abstract Introduction: While overall survival for pediatric acute lymphoblastic leukemia (ALL) now approaches 90%, new treatment options are urgently required…”
Get full text